EPTIS
BAM Logo

AU-5: Autoimmunity scheme - Diabetes antibodies

[AU-5 Autoanticuerpos en Diabetes]

EPTIS factsheet 135569 | Last revision 2015-10-30 | URL: https://www.eptis.bam.de/pts135569 https://www.eptis.bam.de/pts135569

PT provider
PT provider GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology) GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology)
Based in Spain
Language(s)
Remarks
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Human serum Anti pancreatic islets antibodies (ICA) Indirect ImmunoFlourescence (IIF)
Anti glutamate descarboxilase antibodies antibodies (GAD) Blot
Anti tyrosine phosphatase antibodies (IA2) Luminex
Anti insuline antibodies ELISA
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants 10
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by Spanish Society for Immunology
Fees and frequency
Participation fee 137.5 euro
Regularly operated Yes (two times per year)
Year of first operation 2012
Contact details of the PT provider
Provider Contact person
GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology)
Pº de Filipinos s/n
47007 Valladolid
Spain

Phone: +34 983 41 88 23 Ext.89673
Fax:
Web: https://www.geclid.es https://www.geclid.es
Dr. Carmen Martin
Phone: +34 686 247 331
Fax:
Email: responsable@geclid.es responsable@geclid.es
If you find any mistakes please contact the responsible EPTIS coordinator in Spain, Mr Miquel Navarro. Mr Miquel Navarro.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21